1. Home
  2. RYI vs HUMA Comparison

RYI vs HUMA Comparison

Compare RYI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYI
  • HUMA
  • Stock Information
  • Founded
  • RYI 1842
  • HUMA 2004
  • Country
  • RYI United States
  • HUMA United States
  • Employees
  • RYI N/A
  • HUMA N/A
  • Industry
  • RYI Metal Fabrications
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYI Industrials
  • HUMA Health Care
  • Exchange
  • RYI Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • RYI 699.3M
  • HUMA 367.6M
  • IPO Year
  • RYI N/A
  • HUMA N/A
  • Fundamental
  • Price
  • RYI $22.55
  • HUMA $2.25
  • Analyst Decision
  • RYI Hold
  • HUMA Strong Buy
  • Analyst Count
  • RYI 1
  • HUMA 7
  • Target Price
  • RYI $25.00
  • HUMA $13.00
  • AVG Volume (30 Days)
  • RYI 236.5K
  • HUMA 3.3M
  • Earning Date
  • RYI 07-29-2025
  • HUMA 08-12-2025
  • Dividend Yield
  • RYI 3.48%
  • HUMA N/A
  • EPS Growth
  • RYI N/A
  • HUMA N/A
  • EPS
  • RYI N/A
  • HUMA N/A
  • Revenue
  • RYI $4,495,200,000.00
  • HUMA $517,000.00
  • Revenue This Year
  • RYI $0.35
  • HUMA N/A
  • Revenue Next Year
  • RYI $3.40
  • HUMA $896.45
  • P/E Ratio
  • RYI N/A
  • HUMA N/A
  • Revenue Growth
  • RYI N/A
  • HUMA N/A
  • 52 Week Low
  • RYI $17.18
  • HUMA $1.15
  • 52 Week High
  • RYI $27.41
  • HUMA $9.79
  • Technical
  • Relative Strength Index (RSI)
  • RYI 51.78
  • HUMA 41.39
  • Support Level
  • RYI $19.02
  • HUMA $2.09
  • Resistance Level
  • RYI $22.39
  • HUMA $2.26
  • Average True Range (ATR)
  • RYI 0.83
  • HUMA 0.13
  • MACD
  • RYI 0.14
  • HUMA -0.06
  • Stochastic Oscillator
  • RYI 70.62
  • HUMA 5.57

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: